GenomeNet

Database: PDB
Entry: 2XFI
LinkDB: 2XFI
Original site: 2XFI 
HEADER    HYDROLASE                               24-MAY-10   2XFI              
TITLE     HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 
TITLE    2 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-      
TITLE    3 ((METHYLSULFONYL)(PHENYL)AMINO)BENZAMIDE                             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: BETA-SECRETASE 1;                                          
COMPND   3 CHAIN: A;                                                            
COMPND   4 FRAGMENT: RESIDUES 61-452;                                           
COMPND   5 SYNONYM: BACE-1, BETA-SITE AMYLOID PRECURSOR PROTEIN CLEAVING ENZYME 
COMPND   6 1, BETA-SITE APP CLEAVING ENZYME 1, MEMBRANE-ASSOCIATED ASPARTIC     
COMPND   7 PROTEASE 2, MEMAPSIN-2, ASPARTYL PROTEASE 2, ASP2, ASP 2;            
COMPND   8 EC: 3.4.23.46;                                                       
COMPND   9 ENGINEERED: YES;                                                     
COMPND  10 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS;                               
SOURCE   6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER;                           
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 10029;                                      
SOURCE   8 EXPRESSION_SYSTEM_TISSUE: OVARY                                      
KEYWDS    HYDROLASE, PROTEASE, ZYMOGEN                                          
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    B.CLARKE,L.CUTLER,E.DEMONT,C.DINGWALL,R.DUNSDON,J.HAWKINS,C.HOWES,    
AUTHOR   2 I.HUSSAIN,G.MAILE,R.MATICO,J.MOSLEY,A.NAYLOR,A.O'BRIEN,S.REDSHAW,    
AUTHOR   3 P.ROWLAND,V.SOLEIL,K.J.SMITH,S.SWEITZER,P.THEOBALD,D.VESEY,          
AUTHOR   4 D.S.WALTER,G.WAYNE                                                   
REVDAT   4   15-MAY-19 2XFI    1       REMARK                                   
REVDAT   3   06-MAR-19 2XFI    1       REMARK                                   
REVDAT   2   28-JUL-10 2XFI    1       JRNL                                     
REVDAT   1   07-JUL-10 2XFI    0                                                
JRNL        AUTH   B.CLARKE,L.CUTLER,E.DEMONT,C.DINGWALL,R.DUNSDON,J.HAWKINS,   
JRNL        AUTH 2 C.HOWES,I.HUSSAIN,G.MAILE,R.MATICO,J.MOSLEY,A.NAYLOR,        
JRNL        AUTH 3 A.O'BRIEN,S.REDSHAW,P.ROWLAND,V.SOLEIL,K.J.SMITH,S.SWEITZER, 
JRNL        AUTH 4 P.THEOBALD,D.VESEY,D.S.WALTER,G.WAYNE                        
JRNL        TITL   BACE-1 INHIBITORS USING NOVEL EDGE-TO-FACE INTERACTION WITH  
JRNL        TITL 2 ARG-296                                                      
JRNL        REF    BIOORG.MED.CHEM.LETT.         V.  20  4639 2010              
JRNL        REFN                   ISSN 0960-894X                               
JRNL        PMID   20579874                                                     
JRNL        DOI    10.1016/J.BMCL.2010.05.111                                   
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.73 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.5.0109                                      
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 62.01                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
REMARK   3   COMPLETENESS FOR RANGE        (%) : 97.1                           
REMARK   3   NUMBER OF REFLECTIONS             : 38878                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.172                           
REMARK   3   R VALUE            (WORKING SET) : 0.171                           
REMARK   3   FREE R VALUE                     : 0.198                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.000                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 1628                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : 20                           
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.73                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.77                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 2258                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 77.84                        
REMARK   3   BIN R VALUE           (WORKING SET) : 0.1880                       
REMARK   3   BIN FREE R VALUE SET COUNT          : 95                           
REMARK   3   BIN FREE R VALUE                    : 0.2170                       
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2934                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 43                                      
REMARK   3   SOLVENT ATOMS            : 402                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 22.10                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.86000                                              
REMARK   3    B22 (A**2) : 0.37000                                              
REMARK   3    B33 (A**2) : -1.24000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.112         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.104         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.064         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.932         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.966                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.955                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  3149 ; 0.010 ; 0.022       
REMARK   3   BOND LENGTHS OTHERS               (A):  2068 ; 0.001 ; 0.020       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  4303 ; 1.297 ; 1.961       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  5038 ; 0.834 ; 3.000       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   392 ; 6.341 ; 5.000       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   141 ;32.683 ;23.830       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   497 ;11.461 ;15.000       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    18 ;15.329 ;15.000       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   463 ; 0.077 ; 0.200       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  3605 ; 0.005 ; 0.021       
REMARK   3   GENERAL PLANES OTHERS             (A):   660 ; 0.001 ; 0.020       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  1912 ; 0.742 ; 1.500       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):   778 ; 0.153 ; 1.500       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  3117 ; 1.393 ; 2.000       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  1237 ; 2.052 ; 3.000       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  1186 ; 3.492 ; 4.500       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : BABINET MODEL WITH MASK                              
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.40                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS.                                                          
REMARK   4                                                                      
REMARK   4 2XFI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-10.                  
REMARK 100 THE DEPOSITION ID IS D_1290044056.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : NULL                               
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ESRF                               
REMARK 200  BEAMLINE                       : ID14-4                             
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9393                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC CCD                           
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 40540                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.700                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 25.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : 0.000                              
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.7                               
REMARK 200  DATA REDUNDANCY                : 4.700                              
REMARK 200  R MERGE                    (I) : 0.06000                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 23.2000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.73                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.9                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.18000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 6.800                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER                        
REMARK 200 SOFTWARE USED: NULL                                                  
REMARK 200 STARTING MODEL: NONE                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NONE                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 38.32                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS GROWN BY VAPOUR DIFFUSION AT    
REMARK 280  20C USING STREAK SEEDING, WITH 10% PEG8000 AND 0.1M GLYCINE PH      
REMARK 280  3.2, VAPOR DIFFUSION, TEMPERATURE 293K                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21                       
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X+1/2,-Y,Z+1/2                                         
REMARK 290       3555   -X,Y+1/2,-Z+1/2                                         
REMARK 290       4555   X+1/2,-Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       24.16700            
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       52.34750            
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       38.47650            
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       52.34750            
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       24.16700            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       38.47650            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 400                                                                      
REMARK 400 COMPOUND                                                             
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 153 TO GLN                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 172 TO GLN                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 223 TO GLN                        
REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 354 TO GLN                        
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     VAL A    61                                                      
REMARK 465     GLY A   217                                                      
REMARK 465     ALA A   218                                                      
REMARK 465     GLY A   219                                                      
REMARK 465     PHE A   220                                                      
REMARK 465     PRO A   221                                                      
REMARK 465     LEU A   222                                                      
REMARK 465     GLN A   223                                                      
REMARK 465     GLN A   224                                                      
REMARK 465     SER A   225                                                      
REMARK 465     GLU A   226                                                      
REMARK 465     VAL A   227                                                      
REMARK 465     LEU A   228                                                      
REMARK 465     ALA A   229                                                      
REMARK 465     PRO A   448                                                      
REMARK 465     GLN A   449                                                      
REMARK 465     THR A   450                                                      
REMARK 465     ASP A   451                                                      
REMARK 465     GLU A   452                                                      
REMARK 470                                                                      
REMARK 470 MISSING ATOM                                                         
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
REMARK 470 I=INSERTION CODE):                                                   
REMARK 470   M RES CSSEQI  ATOMS                                                
REMARK 470     LEU A 438    CG   CD1  CD2                                       
REMARK 470     ILE A 447    CA   C    O    CB   CG1  CG2  CD1                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   O    HOH A  2352     O    HOH A  2357              2.03            
REMARK 500   NE2  GLN A   365     O    HOH A  2325              2.05            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    PHE A 169      -63.87   -100.97                                   
REMARK 500    TRP A 258      -87.72   -142.36                                   
REMARK 500    ASN A 270       49.38     39.33                                   
REMARK 500    GLN A 354       17.41     59.98                                   
REMARK 500    ASP A 372      116.29   -160.65                                   
REMARK 500    ASP A 372      116.18   -160.65                                   
REMARK 500    HIS A 423      153.01     29.50                                   
REMARK 500    ASP A 424     -164.76   -113.88                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 700                                                                      
REMARK 700 SHEET                                                                
REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN               
REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW,          
REMARK 700 TWO SHEETS ARE DEFINED.                                              
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XFI A 1448                
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1XN3   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONGINHIBITOR WITH    
REMARK 900 ADDITIONAL UPSTREAM RESIDUES.                                        
REMARK 900 RELATED ID: 2WF3   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO )-N-((1S,2R)-2-HYDROXY-3- 
REMARK 900 (((3-(METHYLOXY )PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL )-1-    
REMARK 900 METHYL-1,3,4,5-TETRAHYDRO-2,1- BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-    
REMARK 900 DIOXIDE                                                              
REMARK 900 RELATED ID: 2WF1   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N -((1S,2R)-2-HYDROXY-3-(((3-   
REMARK 900 (METHYLOXY) PHENYL(METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)- 1-METHYL-  
REMARK 900 3,4-DIHYDRO-1H-(1,2,5) THIADIAZEPINO(3,4,5-HI)INDOLE-9- CARBOXAMIDE  
REMARK 900 2,2-DIOXIDE                                                          
REMARK 900 RELATED ID: 2VNM   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 3-(1,1- DIOXIDOTETRAHYDRO-2H-1,2-       
REMARK 900 THIAZIN-2-YL)-5 -(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL) 
REMARK 900 -3-(((3-(TRIFLUOROMETHYL)PHENYL) METHYL)AMINO)PROPYL)BENZAMIDE       
REMARK 900 RELATED ID: 2WF4   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 6-ETHYL-1- METHYL-N-((1S)-2-OXO-1-      
REMARK 900 (PHENYLMETHYL)-3-( TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL)-1,3 ,4,6-   
REMARK 900 TETRAHYDRO(1,2)THIAZEPINO(5,4,3- CD)INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE 
REMARK 900 RELATED ID: 2FDP   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH AN AMINO-         
REMARK 900 ETHYLENE INHIBITOR                                                   
REMARK 900 RELATED ID: 2VJ6   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(((1S)-2-                 
REMARK 900 (CYCLOHEXYLAMINO)-1-METHYL-2- OXOETHYL)AMINO)-2-HYDROXY-1-           
REMARK 900 (PHENYLMETHYL) PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1- PYRROLIDINYL)      
REMARK 900 BENZAMIDE                                                            
REMARK 900 RELATED ID: 1YM4   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITHNVP-AMK640   
REMARK 900 RELATED ID: 2WF2   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 8-ETHYL-N -((1S,2R)-2-HYDROXY-3-(((3-   
REMARK 900 (METHYLOXY) PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)- 1-METHYL-  
REMARK 900 3,4,7,8-TETRAHYDRO-1H,6H-(1, 2,5)THIADIAZEPINO(5,4,3-DE)QUINOXALINE- 
REMARK 900 10-CARBOXAMIDE 2,2-DIOXIDE                                           
REMARK 900 RELATED ID: 1SGZ   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTICDOMAIN.         
REMARK 900 RELATED ID: 1UJK   RELATED DB: PDB                                   
REMARK 900 VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH C -TERMINALPHOSPHOPEPTIDE    
REMARK 900 FROM BACE                                                            
REMARK 900 RELATED ID: 2VA7   RELATED DB: PDB                                   
REMARK 900 X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27 
REMARK 900 RELATED ID: 2WJO   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE (BETA SECRETASE) IN COMPLEX WITH CYCLOHEXANECARBOXYLIC    
REMARK 900 ACID (2-(2-AM INO-6 -PHENOXY-4H-QUINAZOLIN-3-YL)-2 -CYCLOHEXYL -     
REMARK 900 ETHYL)-AMIDE                                                         
REMARK 900 RELATED ID: 2WEZ   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 1-ETHYL-N -((1S,2R)-2-HYDROXY-3-(((3-   
REMARK 900 (METHYLOXY) PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)- 4-(2-OXO-  
REMARK 900 1-PYRROLIDINYL)-1H-INDOLE-6- CARBOXAMIDE                             
REMARK 900 RELATED ID: 1YM2   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITHNVP-AUR200   
REMARK 900 RELATED ID: 1PY1   RELATED DB: PDB                                   
REMARK 900 COMPLEX OF GGA1-VHS DOMAIN AND BETA- SECRETASE C-                    
REMARK 900 TERMINALPHOSPHOPEPTIDE                                               
REMARK 900 RELATED ID: 1W50   RELATED DB: PDB                                   
REMARK 900 APO STRUCTURE OF BACE (BETA SECRETASE)                               
REMARK 900 RELATED ID: 2VJ7   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 3-(ETHYLAMINO )-N-((1S,2R)-2-HYDROXY-1- 
REMARK 900 (PHENYLMETHYL)-3 -(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL) 
REMARK 900 -5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE                                   
REMARK 900 RELATED ID: 2WF0   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 4-ETHYL-N -((1S,2R)-2-HYDROXY-1-        
REMARK 900 (PHENYLMETHYL)-3-((( 3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL ) 
REMARK 900 -8-(2-OXO-1-PYRROLIDINYL)-6- QUINOLINECARBOXAMIDE                    
REMARK 900 RELATED ID: 1W51   RELATED DB: PDB                                   
REMARK 900 BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC       
REMARK 900 INHIBITOR                                                            
REMARK 900 RELATED ID: 1TQF   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH L-124,671   
REMARK 900 RELATED ID: 1M4H   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITHINHIBITOR OM00-3   
REMARK 900 RELATED ID: 1XN2   RELATED DB: PDB                                   
REMARK 900 NEW SUBSTRATE BINDING POCKETS FOR BETA- SECRETASE.                   
REMARK 900 RELATED ID: 2VIY   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(((1S)-2-                 
REMARK 900 (CYCLOHEXYLAMINO)-1-METHYL-2- OXOETHYL)AMINO)-2-HYDROXY-1-           
REMARK 900 (PHENYLMETHYL) PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE                   
REMARK 900 RELATED ID: 2VA6   RELATED DB: PDB                                   
REMARK 900 X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 24 
REMARK 900 RELATED ID: 2VIE   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-1-BENZYL-2-HYDROXY-3-((1,1, 
REMARK 900 5- TRIMETHYLHEXYL)AMINO)PROPYL)-3-(ETHYLAMINO)-5 -(2-OXOPYRROLIDIN-  
REMARK 900 1-YL)BENZAMIDE                                                       
REMARK 900 RELATED ID: 2VIZ   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(((1S)-2-                 
REMARK 900 (CYCLOHEXYLAMINO)-1-METHYL-2- OXOETHYL)AMINO)-2-HYDROXY-1-           
REMARK 900 (PHENYLMETHYL) PROPYL)-3-(2-OXO-1-PYRROLIDINYL)-5-( PROPYLOXY)       
REMARK 900 BENZAMIDE                                                            
REMARK 900 RELATED ID: 2B8L   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH L-000384950 
REMARK 900 RELATED ID: 2VA5   RELATED DB: PDB                                   
REMARK 900 X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8C 
REMARK 900 RELATED ID: 2B8V   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH L-L000430,  
REMARK 900 469                                                                  
REMARK 900 RELATED ID: 1FKN   RELATED DB: PDB                                   
REMARK 900 STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR                 
REMARK 900 RELATED ID: 1XS7   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE- DERIVED NOVELINHIBITOR   
REMARK 900 BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE).                    
REMARK 900 RELATED ID: 2VIJ   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 3-(1,1- DIOXIDOTETRAHYDRO-2H-1,2-       
REMARK 900 THIAZIN-2-YL)-5 -(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL) 
REMARK 900 -3-(1,2,3,4-TETRAHYDRO-1- NAPHTHALENYLAMINO)PROPYL)BENZAMIDE         
REMARK 900 RELATED ID: 2VJ9   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(CYCLOHEXYLAMINO)-2-      
REMARK 900 HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO -1-         
REMARK 900 PYRROLIDINYL)BENZAMIDE                                               
REMARK 900 RELATED ID: 2VKM   RELATED DB: PDB                                   
REMARK 900 CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE)         
REMARK 900 RELATED ID: 2VNN   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N -((1S,2R)-2-HYDROXY-1-        
REMARK 900 (PHENYLMETHYL)-3-((( 3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL ) 
REMARK 900 -1-METHYL-3,4-DIHYDRO-1H-(1,2,5) THIADIAZEPINO(3,4,5-HI)INDOLE-9-    
REMARK 900 CARBOXAMIDE 2,2-DIOXIDE                                              
REMARK 900 RELATED ID: 1UJJ   RELATED DB: PDB                                   
REMARK 900 VHS DOMAIN OF HUMAN GGA1 COMPLEXED WITH C -TERMINAL PEPTIDEFROM BACE 
REMARK 900 RELATED ID: 2XFJ   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(((1S)-2-                 
REMARK 900 (CYCLOHEXYLAMINO)-1-METHYL-2- OXOETHYL)AMINO)-2-HYDROXY-1-           
REMARK 900 (PHENYLMETHYL) PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1- PYRROLIDINYL)      
REMARK 900 BENZAMIDE                                                            
REMARK 900 RELATED ID: 2XFK   RELATED DB: PDB                                   
REMARK 900 HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R )-3-(((1S)-2-                 
REMARK 900 (CYCLOHEXYLAMINO)-1-METHYL-2- OXOETHYL)AMINO)-2-HYDROXY-1-           
REMARK 900 (PHENYLMETHYL) PROPYL)-3-(ETHYLAMINO)-5-((METHYLSULFONYL)( PHENYL)   
REMARK 900 AMINO)BENZAMIDE                                                      
DBREF  2XFI A   61   452  UNP    P56817   BACE1_HUMAN     61    452             
SEQADV 2XFI GLN A  153  UNP  P56817    ASN   153 ENGINEERED MUTATION            
SEQADV 2XFI GLN A  172  UNP  P56817    ASN   172 ENGINEERED MUTATION            
SEQADV 2XFI GLN A  223  UNP  P56817    ASN   223 ENGINEERED MUTATION            
SEQADV 2XFI GLN A  354  UNP  P56817    ASN   354 ENGINEERED MUTATION            
SEQRES   1 A  392  VAL GLU MET VAL ASP ASN LEU ARG GLY LYS SER GLY GLN          
SEQRES   2 A  392  GLY TYR TYR VAL GLU MET THR VAL GLY SER PRO PRO GLN          
SEQRES   3 A  392  THR LEU ASN ILE LEU VAL ASP THR GLY SER SER ASN PHE          
SEQRES   4 A  392  ALA VAL GLY ALA ALA PRO HIS PRO PHE LEU HIS ARG TYR          
SEQRES   5 A  392  TYR GLN ARG GLN LEU SER SER THR TYR ARG ASP LEU ARG          
SEQRES   6 A  392  LYS GLY VAL TYR VAL PRO TYR THR GLN GLY LYS TRP GLU          
SEQRES   7 A  392  GLY GLU LEU GLY THR ASP LEU VAL SER ILE PRO HIS GLY          
SEQRES   8 A  392  PRO GLN VAL THR VAL ARG ALA ASN ILE ALA ALA ILE THR          
SEQRES   9 A  392  GLU SER ASP LYS PHE PHE ILE GLN GLY SER ASN TRP GLU          
SEQRES  10 A  392  GLY ILE LEU GLY LEU ALA TYR ALA GLU ILE ALA ARG PRO          
SEQRES  11 A  392  ASP ASP SER LEU GLU PRO PHE PHE ASP SER LEU VAL LYS          
SEQRES  12 A  392  GLN THR HIS VAL PRO ASN LEU PHE SER LEU GLN LEU CYS          
SEQRES  13 A  392  GLY ALA GLY PHE PRO LEU GLN GLN SER GLU VAL LEU ALA          
SEQRES  14 A  392  SER VAL GLY GLY SER MET ILE ILE GLY GLY ILE ASP HIS          
SEQRES  15 A  392  SER LEU TYR THR GLY SER LEU TRP TYR THR PRO ILE ARG          
SEQRES  16 A  392  ARG GLU TRP TYR TYR GLU VAL ILE ILE VAL ARG VAL GLU          
SEQRES  17 A  392  ILE ASN GLY GLN ASP LEU LYS MET ASP CYS LYS GLU TYR          
SEQRES  18 A  392  ASN TYR ASP LYS SER ILE VAL ASP SER GLY THR THR ASN          
SEQRES  19 A  392  LEU ARG LEU PRO LYS LYS VAL PHE GLU ALA ALA VAL LYS          
SEQRES  20 A  392  SER ILE LYS ALA ALA SER SER THR GLU LYS PHE PRO ASP          
SEQRES  21 A  392  GLY PHE TRP LEU GLY GLU GLN LEU VAL CYS TRP GLN ALA          
SEQRES  22 A  392  GLY THR THR PRO TRP ASN ILE PHE PRO VAL ILE SER LEU          
SEQRES  23 A  392  TYR LEU MET GLY GLU VAL THR GLN GLN SER PHE ARG ILE          
SEQRES  24 A  392  THR ILE LEU PRO GLN GLN TYR LEU ARG PRO VAL GLU ASP          
SEQRES  25 A  392  VAL ALA THR SER GLN ASP ASP CYS TYR LYS PHE ALA ILE          
SEQRES  26 A  392  SER GLN SER SER THR GLY THR VAL MET GLY ALA VAL ILE          
SEQRES  27 A  392  MET GLU GLY PHE TYR VAL VAL PHE ASP ARG ALA ARG LYS          
SEQRES  28 A  392  ARG ILE GLY PHE ALA VAL SER ALA CYS HIS VAL HIS ASP          
SEQRES  29 A  392  GLU PHE ARG THR ALA ALA VAL GLU GLY PRO PHE VAL THR          
SEQRES  30 A  392  LEU ASP MET GLU ASP CYS GLY TYR ASN ILE PRO GLN THR          
SEQRES  31 A  392  ASP GLU                                                      
HET    XFI  A1448      43                                                       
HETNAM     XFI N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)-1-METHYL-2-              
HETNAM   2 XFI  OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-           
HETNAM   3 XFI  ((METHYLSULFONYL)(PHENYL)AMINO) BENZAMIDE                       
FORMUL   2  XFI    C33 H42 N4 O5 S                                              
FORMUL   3  HOH   *402(H2 O)                                                    
HELIX    1   1 GLN A  114  SER A  118  5                                   5    
HELIX    2   2 TYR A  184  ALA A  188  5                                   5    
HELIX    3   3 PRO A  196  THR A  205  1                                  10    
HELIX    4   4 ASP A  241  SER A  243  5                                   3    
HELIX    5   5 ASP A  277  TYR A  283  5                                   7    
HELIX    6   6 LYS A  299  SER A  313  1                                  15    
HELIX    7   7 PRO A  319  LEU A  324  1                                   6    
HELIX    8   8 PRO A  337  PHE A  341  5                                   5    
HELIX    9   9 LEU A  362  TYR A  366  1                                   5    
HELIX   10  10 ASP A  372  SER A  376  5                                   5    
HELIX   11  11 GLY A  395  GLU A  400  1                                   6    
SHEET    1  AA 3 ARG A 122  PRO A 131  0                                        
SHEET    2  AA 3 LYS A 136  SER A 147 -1  O  TRP A 137   N  VAL A 130           
SHEET    3  AA 3 TYR A  75  VAL A  81 -1  O  THR A  80   N  SER A 147           
SHEET    1  AB 2 ARG A 122  PRO A 131  0                                        
SHEET    2  AB 2 LYS A 136  SER A 147 -1  O  TRP A 137   N  VAL A 130           
SHEET    1  AC 5 GLU A 261  VAL A 262  0                                        
SHEET    2  AC 5 SER A 286  VAL A 288 -1  O  SER A 286   N  VAL A 262           
SHEET    3  AC 5 THR A 392  MET A 394  1  O  THR A 392   N  ILE A 287           
SHEET    4  AC 5 LEU A 295  PRO A 298 -1  O  ARG A 296   N  VAL A 393           
SHEET    5  AC 5 ILE A 385  SER A 388  1  O  SER A 386   N  LEU A 297           
SHEET    1  AD 5 GLN A 272  ASP A 273  0                                        
SHEET    2  AD 5 ILE A 264  ILE A 269 -1  O  ILE A 269   N  GLN A 272           
SHEET    3  AD 5 ILE A 344  MET A 349 -1  O  SER A 345   N  GLU A 268           
SHEET    4  AD 5 GLN A 355  ILE A 361 -1  O  PHE A 357   N  LEU A 348           
SHEET    5  AD 5 ALA A 430  VAL A 436 -1  O  ALA A 430   N  THR A 360           
SHEET    1  AE 3 VAL A 329  GLN A 332  0                                        
SHEET    2  AE 3 ASP A 378  PHE A 383 -1  O  ASP A 379   N  TRP A 331           
SHEET    3  AE 3 LEU A 367  PRO A 369 -1  O  ARG A 368   N  LYS A 382           
SSBOND   1 CYS A  216    CYS A  420                          1555   1555  2.05  
SSBOND   2 CYS A  278    CYS A  443                          1555   1555  2.06  
SSBOND   3 CYS A  330    CYS A  380                          1555   1555  2.08  
CISPEP   1 SER A   83    PRO A   84          0        -2.04                     
CISPEP   2 SER A   83    PRO A   84          0        -3.63                     
CISPEP   3 ARG A  189    PRO A  190          0         4.29                     
CISPEP   4 TYR A  283    ASP A  284          0         0.84                     
CISPEP   5 GLY A  433    PRO A  434          0        -1.38                     
SITE     1 AC1 20 LEU A  91  ASP A  93  GLY A  95  SER A  96                    
SITE     2 AC1 20 VAL A 130  PRO A 131  TYR A 132  THR A 133                    
SITE     3 AC1 20 GLN A 134  PHE A 169  ILE A 179  TYR A 259                    
SITE     4 AC1 20 ASP A 289  GLY A 291  THR A 292  THR A 293                    
SITE     5 AC1 20 ASN A 294  ARG A 296  SER A 386  HOH A2402                    
CRYST1   48.334   76.953  104.695  90.00  90.00  90.00 P 21 21 21    4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.020689  0.000000  0.000000        0.00000                         
SCALE2      0.000000  0.012995  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.009552        0.00000                         
(ATOM LINES ARE NOT SHOWN.)
END                                                                             
DBGET integrated database retrieval system